(Q98394813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

14 August 2020

title

The type I interferon response in COVID-19: implications for treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

14 August 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

14 August 2020

Eui-Cheol Shin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

14 August 2020

publication date

12 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Immunology

14 August 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

14 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Longitudinal analyses reveal immunological misfiring in severe COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation.

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41577-020-00429-3

7 January 2021

10.1038/S41577-020-00429-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32788708%20AND%20SRC:MED&resulttype=core&format=json

14 August 2020

1 reference